Startups
Synspira Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to significantly improving the lives of people with cystic fibrosis (CF) and other rare diseases. Inspired by patients, Synspira is focused on developing a rationally designed portfolio of products that can make a life-changing impact and improve the quality of life of patients. Synspira is working to advance two novel products (SNSP113 and SNSP003) intended to provide better clinical outcomes and reduce treatment burden in pulmonary disease as well as malabsorption syndromes and exocrine pancreatic insufficiency. SNSP113, Synspira’s lead product, is in a Phase 2 clinical study in people with cystic fibrosis. Synspira is a privately held company headquartered in Framingham, MA.
Overview
Location
United States, Massachusetts, Framingham
Employees
1-10
Total raised
$25M
Founded date
2017
Funding Rounds 3
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Jan 3, 2018 | Funding round | $3M | |
| Jun 29, 2017 | Funding round | $8M |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 29, 2017 | Synspira Raises $8M in Funding | Synspira, a Boston, MA-based company developing a new class of glycopolymer-based therapeutics for pulmonary disease, secured $8m in funding. The company intends to use the funds to advance a Phase 1 first-in-humans safety study of SNSP113.... |
Reviews 0
FAQ about Synspira Therapeutics, Inc.
When was Synspira Therapeutics, Inc. founded?
Synspira Therapeutics, Inc. was founded in 2017.
How much funding has Synspira Therapeutics, Inc. raised?
Synspira Therapeutics, Inc. has raised $25M in total across 3 funding rounds.
What funding rounds has Synspira Therapeutics, Inc. raised?
Parsers VC lists 3 funding rounds of Synspira Therapeutics, Inc., among them a funding round of $3M on Jan 3, 2018 and a funding round of $8M on Jun 29, 2017.
What has the press written about Synspira Therapeutics, Inc.?
Parsers VC has collected 2 articles mentioning Synspira Therapeutics, Inc., among them “Synspira Raises $8M in Funding” (Jun 29, 2017).
Is Synspira Therapeutics, Inc. still active?
Yes, Synspira Therapeutics, Inc. is active; its latest activity on Parsers VC dates from Jun 29, 2017.